Log in to save to my catalogue

Galectin‐3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1‐induced ma...

Galectin‐3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1‐induced ma...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3987071

Galectin‐3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1‐induced macrophages

About this item

Full title

Galectin‐3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1‐induced macrophages

Publisher

United States: John Wiley & Sons Ltd

Journal title

Cancer medicine (Malden, MA), 2014-04, Vol.3 (2), p.201-214

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons Ltd

More information

Scope and Contents

Contents

In order to study the role of galectin‐3 in tumor angiogenesis associated with tumor‐associated macrophages (TAM) and tumor parenchyma, the galectin‐3 expression was reconstituted in Tm1 melanoma cell line that lacks this protein. Galectin‐3‐expressing cells (Tm1G3) and mock‐vector transfected cells (Tm1N3) were injected into wild‐type (WT) and gal...

Alternative Titles

Full title

Galectin‐3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1‐induced macrophages

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3987071

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3987071

Other Identifiers

ISSN

2045-7634

E-ISSN

2045-7634

DOI

10.1002/cam4.173

How to access this item